Svitozar Khalak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Svitozar Khalak has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Andrii Nakonechnyi
SNPE Danylo Halytskyi Lviv National Medical University, Ukraine
2 shared publications - Andrij Nakonechnyy
Department of Paediatric Surgery, Danylo Halytskyy Lviv National Medical University, 79059 Lviv, Ukraine
1 shared publication
Latest Publications
- 28 March 2026
- Published by Group of Companies Med Expert, LLC in Paediatric Surgery. Ukraine
- No. 1(90),p. 119-124
Radiomics in Wilms' tumor: from visualization to personalized prediction
Wilms’ tumor is the most common malignant renal tumor in children and remains a significant challenge in pediatric oncologic surgery despite high survival rates. The lack of standardized noninvasive methods for the quantitative assessment of imaging data limits the accurate prediction of disease course, risk of recurrence, and bilateral renal involvement. Aim - to analyze current scientific evidence on the application of radiomics in pediatric Wilms’ tumor and to evaluate its diagnostic and prognostic potential for clinical practice. Radiomics is based on the extraction of quantitative textural, morphological, and intensity features from computed tomography images, enabling an objective assessment of tumor heterogeneity. Recent studies demonstrate high effectiveness of radiomics in the differential diagnosis of Wilms’ tumor and other pediatric renal tumors, as well as in predicting treatment response, recurrence risk, and survival outcomes. Conclusions. The integration of radiomic markers with clinical, radiological, and pathomorphological data facilitates the implementation of a personalized treatment approach, contributing to the optimization of surgical tactics and the improvement of long-term outcomes in children with nephroblastoma. The authors declare no conflict of interest.
- 28 March 2026
- Published by Group of Companies Med Expert, LLC in Paediatric Surgery. Ukraine
- No. 1(90),p. 119-124
Radiomics in Wilms' tumor: from visualization to personalized prediction
Wilms’ tumor is the most common malignant renal tumor in children and remains a significant challenge in pediatric oncologic surgery despite high survival rates. The lack of standardized noninvasive methods for the quantitative assessment of imaging data limits the accurate prediction of disease course, risk of recurrence, and bilateral renal involvement. Aim - to analyze current scientific evidence on the application of radiomics in pediatric Wilms’ tumor and to evaluate its diagnostic and prognostic potential for clinical practice. Radiomics is based on the extraction of quantitative textural, morphological, and intensity features from computed tomography images, enabling an objective assessment of tumor heterogeneity. Recent studies demonstrate high effectiveness of radiomics in the differential diagnosis of Wilms’ tumor and other pediatric renal tumors, as well as in predicting treatment response, recurrence risk, and survival outcomes. Conclusions. The integration of radiomic markers with clinical, radiological, and pathomorphological data facilitates the implementation of a personalized treatment approach, contributing to the optimization of surgical tactics and the improvement of long-term outcomes in children with nephroblastoma. The authors declare no conflict of interest.
- Open Access
- 12 March 2026
- Published by Springer Nature in BMC Pediatrics
- Vol. 26 (1)
Erdheim–Chester disease mimicking Wilms tumor in a child: a diagnostic challenge
Erdheim–Chester disease (ECD) is a rare non-Langerhans cell histiocytosis driven by activating mutations of the MAPK signaling pathway, most commonly
- 12 March 2026
- Published by Springer Nature in BMC Pediatrics
- Vol. 26 (1)
Open AccessErdheim–Chester disease mimicking Wilms tumor in a child: a diagnostic challenge
Erdheim–Chester disease (ECD) is a rare non-Langerhans cell histiocytosis driven by activating mutations of the MAPK signaling pathway, most commonly
- Open Access
- 25 January 2026
- Published by Springer Nature in Research Square
Erdheim–Chester Disease Mimicking Wilms Tumor in a Child: A Diagnostic Challenge
Background Erdheim–Chester disease (ECD) is a rare non-Langerhans cell histiocytosis driven by activating mutations of the MAPK signaling pathway, most commonly BRAF V600E. Pediatric cases are exceedingly rare and often present with atypical, multisystem manifestations, resulting in significant diagnostic delay. Renal and retroperitoneal involvement may mimic primary renal malignancies, particularly Wilms tumor. Case presentation We report a case of Erdheim–Chester disease in Ukraine, Lviv. A male child who initially presented at the age of two years with central diabetes insipidus and progressive urinary tract infections. Over two years, the patient developed bilateral obstructive uropathy, retroperitoneal and paravertebral masses, and multifocal central nervous system and orbital involvement. Recurrent urinary tract infections and progressive hydronephrosis necessitated multiple surgical interventions. Initial histopathological findings were inconclusive and suggested alternative diagnoses, including ganglioneuroma and reactive histiocytic proliferation. Due to discordance between clinical, radiological, and histological findings, extended immunohistochemical and molecular analyses were performed. Detection of a pathogenic BRAF V600E mutation confirmed the diagnosis of Erdheim–Chester disease. Lifelong targeted therapy with the BRAF inhibitor dabrafenib was initiated, resulting in clinical stabilization. Conclusions This case highlights the diagnostic complexity of Erdheim–Chester disease in children and emphasizes the importance of considering histiocytic disorders in the differential diagnosis of renal and retroperitoneal masses. Multisystem involvement, atypical imaging findings, and molecular testing are key elements for accurate diagnosis and appropriate management, particularly in cases mimicking Wilms tumor.
- 25 January 2026
- Published by Springer Nature in Research Square
Open AccessErdheim–Chester Disease Mimicking Wilms Tumor in a Child: A Diagnostic Challenge
Background Erdheim–Chester disease (ECD) is a rare non-Langerhans cell histiocytosis driven by activating mutations of the MAPK signaling pathway, most commonly BRAF V600E. Pediatric cases are exceedingly rare and often present with atypical, multisystem manifestations, resulting in significant diagnostic delay. Renal and retroperitoneal involvement may mimic primary renal malignancies, particularly Wilms tumor. Case presentation We report a case of Erdheim–Chester disease in Ukraine, Lviv. A male child who initially presented at the age of two years with central diabetes insipidus and progressive urinary tract infections. Over two years, the patient developed bilateral obstructive uropathy, retroperitoneal and paravertebral masses, and multifocal central nervous system and orbital involvement. Recurrent urinary tract infections and progressive hydronephrosis necessitated multiple surgical interventions. Initial histopathological findings were inconclusive and suggested alternative diagnoses, including ganglioneuroma and reactive histiocytic proliferation. Due to discordance between clinical, radiological, and histological findings, extended immunohistochemical and molecular analyses were performed. Detection of a pathogenic BRAF V600E mutation confirmed the diagnosis of Erdheim–Chester disease. Lifelong targeted therapy with the BRAF inhibitor dabrafenib was initiated, resulting in clinical stabilization. Conclusions This case highlights the diagnostic complexity of Erdheim–Chester disease in children and emphasizes the importance of considering histiocytic disorders in the differential diagnosis of renal and retroperitoneal masses. Multisystem involvement, atypical imaging findings, and molecular testing are key elements for accurate diagnosis and appropriate management, particularly in cases mimicking Wilms tumor.